Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Sales | 1,168 | 1,184 | 1,069 | 818 | 721 |
| Cost of Goods | 900 | 901 | 939 | 783 | 717 |
| Gross Profit | 267 | 282 | 130 | 35 | 5 |
| Operating Expenses | 1,376 | 1,467 | 1,371 | 1,223 | 1,170 |
| Operating Income | -208 | -283 | -302 | -405 | -449 |
| Interest Expense | 7 | 5 | 7 | 11 | 16 |
| Other Income | 21 | 66 | 32 | -487 | -231 |
| Pre-tax Income | -194 | -222 | -276 | -903 | -696 |
| Income Tax | 0 | 8 | 6 | 0 | 0 |
| Net Income Continuous | -197 | -217 | -276 | -803 | -602 |
| Net Income Discontinuous | 0 | 171 | 51 | -27 | 0 |
| Net Income | $-197 | $-46 | $-225 | $-831 | $-602 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.04 | -0.15 | -0.11 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.05 | -0.14 | -0.11 |
| EPS Basic Discontinuous Ops | N/A | 0.03 | 0.01 | 0.00 | N/A |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.04 | -0.15 | -0.11 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.05 | -0.14 | -0.11 |
| EPS Diluted Discontinuous Ops | N/A | 0.03 | 0.01 | 0.00 | N/A |
| EBITDA(a) | $-208 | $-283 | $-302 | $-405 | $-449 |